i3 Verticals, Inc. · NASDAQ:IIIV
i3 Verticals — Q4 FY2026 Earnings Presentation
10 slides from i3 Verticals's earnings presentation, Nov 17, 2026
Slide 1: Q4 Fiscal Year 2026 Supplemental Information
1 Q4 FISCAL YEAR 2026 Supplemental Information
Slide 2: Revenue Composition
2 See footnotes continued on the next slide. ($ in thousands) Quarter Ended September 30, 2026 June 30, 2026 March 31, 2026 December 31, 2025 September 30, 2025 June 30, 2025 March 31, 2025 December 31, 2024 Recurring revenue SaaS(2) $ 14,011 $ 12,798 $ 12,658 $ 10,959 $ 10,375 $ 9,299 $ 9,209 $ 8,8
Slide 3: Revenue Composition Footnotes
3 1.) As a result of the sale of our merchant services business (the "Merchant Services Business"), which was completed on September 20, 2024, and the sale of our Healthcare revenue cycle management business (the "Healthcare RCM Business"), which was completed on May 5, 2025, the historical results
Slide 4: Income (Loss) from Operations, Continuing Operations
4 The following is our income (loss) from operations for the current and prior year quarters calculated in accordance with GAAP and presented for continuing operations only. This presentation includes the disclosure of certain non-GAAP financial measures presented by the Company, including the follo
Slide 5: Quarterly Performance
5 Quarterly Performance 1.) Recurring cash costs of services represents recurring operating costs directly related to our revenue generating activities except the stock compensation portion of personnel costs included within costs of services. 2.) Recurring cash SG&A expenses represents recurring op
Slide 6: Adjusted EBITDA Reconciliation
6 ($ in thousands) Three Months Ended September 30, 2026 June 30, 2026 March 31, 2026 December 31, 2025 September 30, 2025 June 30, 2025 March 31, 2025 December 31, 2024 Net (loss) income from continuing operations attributable to i3 Verticals, Inc. $ (2,008) $ 3,620 $ 1,464 $ 576 $ 1,163 $ (410) $
Slide 7: Reconciliation of Non-GAAP Financial Measures
7 Reconciliation of Non-GAAP Financial Measures 1.) As a result of the sale of our merchant services business (the "Merchant Services Business"), which was completed on September 20, 2024, and the sale of our Healthcare revenue cycle management business (the "Healthcare RCM Business"), which was com
Slide 8: Non-GAAP Adjusted Diluted EPS
8 See footnotes on the next slide. Non-GAAP Adjusted Diluted EPS(1) The reconciliation of our GAAP diluted EPS from continuing operations and non-GAAP adjusted diluted EPS from continuing operations for the current and prior year quarters are as follows: ($ in thousands, except share and per share a
Slide 9: Adjusted Diluted EPS Footnotes
9 1.) Diluted net (loss) income per share attributable to Class A common stockholders from continuing operations and adjusted diluted earnings per share from continuing operations both exclude the discontinued operations of the Merchant Services Business and the Healthcare RCM Business but include t
Slide 10: Reconciliation of Free Cash Flow
10 Reconciliation of Free Cash Flow The reconciliation of GAAP net cash provided by operating activities to non-GAAP Free Cash Flow is as follows: ($ in thousands) Three Months Ended September 30, 2026 June 30, 2026 March 31, 2026 December 31, 2025 September 30, 2025 Net cash provided by operating a